Screener
Protagonist Therapeutics PTGX Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $420.08M+149% | $193.71M+38.7% | $128.39M+32.0% | $113.71M-13.3% | $168.54M-52.6% | ||
| $362.5M-9.8% | $354.07M-18.5% | $438.97M+36.5% | $462.4M+37.0% | $401.92M+92.9% | ||
| $807.15M+34.0% | $613.46M+1.3% | $577.57M-2.4% | $586.42M+23.0% | $602.53M+5.5% | ||
| $3.46M-15.9% | $3.78M+7.0% | $3.86M+21.0% | $4.1M+66.1% | $4.11M+131% | ||
| $885.54M+23.3% | $697.46M-6.0% | $668.19M-10.3% | $701.69M+16.2% | $718.01M+16.8% | ||
| $9.66M+79.7% | $6.28M-23.2% | $9.55M-18.2% | $2.79M— | $5.38M— | ||
| $37.18M+4.7% | $34.55M-1.6% | $45.44M-4.1% | $44.94M+0.8% | $35.51M-14.6% | ||
| $44M-12.0% | $41.99M-20.9% | $53.48M-23.0% | $56.25M-21.8% | $49.99M-31.8% | ||
| $1K0.0% | $1K0.0% | $1K0.0% | $1K0.0% | $1K0.0% | ||
| -$304.04M+21.4% | -$466.89M-32.6% | -$470.67M-38.2% | -$426.29M+9.7% | -$386.95M+11.9% | ||
| $841.54M+26.0% | $655.47M-4.9% | $614.71M-9.0% | $645.44M+21.3% | $668.02M+23.4% | ||
| $885.54M+23.3% | $697.46M-6.0% | $668.19M-10.3% | $701.69M+16.2% | $718.01M+16.8% |
FAQ
- What are Protagonist Therapeutics's total assets?
- Protagonist Therapeutics (PTGX) holds $885.5M in total assets, up 23.3% year over year.
- How much debt does Protagonist Therapeutics have?
- Protagonist Therapeutics carries $9.2M in total debt against $841.5M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Protagonist Therapeutics have?
- Protagonist Therapeutics holds $420.1M in cash and equivalents.
- Can Protagonist Therapeutics cover its short-term obligations?
- Its current ratio is 21.71 — current assets exceed current liabilities.
- Where does Protagonist Therapeutics's balance sheet data come from?
- Every line is extracted from Protagonist Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
